Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0027819 (
neuroblastoma
)
27,800
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
How, in the absence of a functional mannose 6-phosphate (Man-6-P)-signal-dependent transport pathway, some acid hydrolases remain sorted to endolysosomes in the brain is poorly understood. We demonstrate that cathepsin D binds to mouse
SEZ6L2
, a type 1 transmembrane protein predominantly expressed in the brain. Studies of the subcellular trafficking of
SEZ6L2
, and its silencing in a mouse
neuroblastoma
cell line reveal that
SEZ6L2
is involved in the trafficking of cathepsin D to endosomes. Moreover,
SEZ6L2
can partially correct the cathepsin D hypersecretion resulting from the knockdown of UDP-GlcNAc:lysosomal enzyme GlcNAc-1-phosphotransferase in HeLa cells (i.e. in cells that are unable to synthesize Man-6-P signals). Interestingly, cleavage of
SEZ6L2
by cathepsin D generates an N-terminal soluble fragment that induces neurite outgrowth, whereas its membrane counterpart prevents this. Taken together, our findings highlight that
SEZ6L2
can serve as receptor to mediate the sorting of cathepsin D to endosomes, and suggest that proteolytic cleavage of
SEZ6L2
by cathepsin D modulates neuronal differentiation.
...
PMID:Cathepsin D and its newly identified transport receptor SEZ6L2 can modulate neurite outgrowth. 2669 17